Nanoscopic dopamine transporter distribution and conformation are inversely regulated by excitatory drive and D2 autoreceptor activity

被引:11
|
作者
Lycas, Matthew D. [1 ]
Ejdrup, Aske L. [1 ]
Sorensen, Andreas T. [1 ]
Haahr, Nicolai O. [1 ]
Jorgensen, Soren H. [1 ]
Guthrie, Daryl A. [2 ]
Stoier, Jonatan F. [1 ]
Werner, Christian [3 ]
Newman, Amy Hauck [2 ]
Sauer, Markus [3 ]
Herborg, Freja [1 ]
Gether, Ulrik [1 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Mol Neuropharmacol & Genet Lab, Maersk Tower 7-5, DK-2200 Copenhagen, Denmark
[2] NIDA, Med Chem Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA
[3] Julius Maximilians Univ Wurzburg, Bioctr, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany
来源
CELL REPORTS | 2022年 / 40卷 / 13期
关键词
MONOAMINE TRANSPORTERS; PLASMA-MEMBRANE; RECEPTORS; COCAINE; ORGANIZATION; D3; ENDOCYTOSIS; GLUTAMATE; RELEASE; BRAIN;
D O I
10.1016/j.celrep.2022.111431
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The nanoscopic organization and regulation of individual molecular components in presynaptic varicosities of neurons releasing modulatory volume neurotransmitters like dopamine (DA) remain largely elusive. Here we show, by application of several super-resolution microscopy techniques to cultured neurons and mouse striatal slices, that the DA transporter (DAT), a key protein in varicosities of dopaminergic neurons, exists in the membrane in dynamic equilibrium between an inward-facing nanodomain-localized and outward-facing unclustered configuration. The balance between these configurations is inversely regulated by excitatory drive and DA D2 autoreceptor activation in a manner dependent on Ca2+ influx via N-type voltage-gated Ca2+ channels. The DAT nanodomains contain tens of transporters molecules and overlap with nanodomains of PIP2 (phosphatidylinositol-4,5-bisphosphate) but show little overlap with D2 autoreceptor, syntaxin-1, and clathrin nanodomains. The data reveal a mechanismfor rapid alterations of nanoscopic DAT distribution and show a striking link of this to the conformational state of the transporter.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Contribution of dopamine D1 and D2 receptors to amygdala activity
    Takahashi, H.
    Otsuka, T.
    Takano, H.
    Kodaka, F.
    Kikyo, H.
    Arakawa, R.
    Miyoshi, M.
    Okumura, M.
    Ito, H.
    Suhara, T.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S109 - S109
  • [42] Constitutive activity of a chimeric D2/D1 dopamine receptor
    Kozell, LB
    Neve, KA
    MOLECULAR PHARMACOLOGY, 1997, 52 (06) : 1137 - 1149
  • [43] Plasma membrane distribution of the Gi proteins and dopamine D2 receptor
    Polit, A.
    Mystek, P.
    Rysiewicz, B.
    Kluz, M.
    Dziedzicka-Wasylewska, M.
    FEBS JOURNAL, 2017, 284 : 16 - 16
  • [44] Paraquat is not a substrate for the dopamine transporter and does not bind to dopamine D1 and D2 receptors in the rat and mouse striatum
    Foster, AJ
    Marks, L
    Lock, EA
    Sturgess, NC
    TOXICOLOGY, 2004, 202 (1-2) : 131 - 132
  • [45] PRENATAL ONTOGENY OF D2 DOPAMINE-RECEPTOR AND DOPAMINE TRANSPORTER GENE-EXPRESSION IN THE RAT MESENCEPHALON
    TISON, F
    NORMAND, E
    BLOCH, B
    NEUROSCIENCE LETTERS, 1994, 166 (01) : 48 - 50
  • [46] Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent
    Mayfield, RD
    Zahniser, NR
    MOLECULAR PHARMACOLOGY, 2001, 59 (01) : 113 - 121
  • [47] THE EFFECTS OF PRENATAL COCAINE EXPOSURE ON DOPAMINE TRANSPORTER AND DOPAMINE D2 RECEPTOR IN THE OFFSPRING - A NORTHERN BLOT ANALYSIS
    CHOI, HL
    STADLIN, A
    TSIM, KWK
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S102 - S102
  • [48] Chronic activation of the D2 autoreceptor inhibits both glutamate and dopamine synapse formation and alters the intrinsic properties of mesencephalic dopamine neurons in vitro
    Fasano, C.
    Kortleven, C.
    Trudeau, L-E
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2010, 32 (09) : 1433 - 1441
  • [49] Combination of dopamine transporter and dopamine D2 receptor binding in the differential diagnosis of patients with Parkinson's disease
    Schwarz, J
    Tatsch, K
    Kerner, M
    Linke, R
    Storch, A
    Trenkwalder, C
    Gasser, T
    Mozeley, D
    NEUROLOGY, 1998, 50 (04) : A390 - A390
  • [50] SYNTHESIS, IDENTIFICATION AND PHARMACOLOGY OF METABOLITES OF CL-1007, A DOPAMINE D2 AUTORECEPTOR AGONIST AND POTENTIAL ANTIPSYCHOTIC AGENT
    DOWNING, DM
    WRIGHT, JL
    WISE, LD
    FENG, MR
    STRENKOSKI, C
    PUGSLEY, TA
    HEFFNER, TG
    MELTZER, LT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 178 - MEDI